Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kienast

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Bone Marrow Transplantation|April 1, 1997
Efficacy and kinetics of bone marrow processing and enrichment of haematopoietic progenitor cells (HPC) by a large-volume apheresis procedureU Cassens, P Ostkamp-Ostermann, H Garritsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 1999
Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapyM Mohr, E Hilgenfeld, T Fietz, et al.
Transplantation Proceedings|November 15, 2002
Mycophenolate mofetil for the prophylaxis of acute graft-versus-host disease in stem cell transplant recipientsM G Kiehl, K Schäfer-Eckart, M Kröger, et al.
Thrombosis and Haemostasis|January 1, 1994
Factor VII-deficient substrate plasmas depleted of protein C raise the sensitivity of the factor VII bio-assay to activated factor VII: an international studyG J Miller, Y Stirling, M P Esnouf, et al.
Bone Marrow Transplantation|February 5, 2013
CD34(+) lineage specific donor cell chimerism for the diagnosis and treatment of impending relapse of AML or myelodysplastic syndrome after allo-SCTF Rosenow, A Berkemeier, U Krug, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2001
Simultaneous immunomagnetic CD34+ cell selection and B-cell depletion in peripheral blood progenitor cell samples of patients suffering from B-cell non-Hodgkin's lymphomaM Mohr, F Dalmis, E Hilgenfeld, et al.
Leukemia|July 3, 2002
Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemiaT Padró, R Bieker, S Ruiz, et al.
Blood|November 23, 2000
Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathwaysM Mizuki, R Fenski, H Halfter, et al.
Leukemia|April 2, 2011
Allogeneic stem cell transplant to eliminate germline mutations in the gene for CCAAT-enhancer-binding protein α from hematopoietic cells in a family with AMLM Stelljes, A Corbacioglu, R F Schlenk, et al.
Annals of Hematology|March 4, 2003
Reduced non-relapse mortality after reduced intensity conditioning in advanced chronic lymphocytic leukemiaJ Schetelig, C Thiede, M Bornhäuser, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Bone Marrow Transplantation|April 1, 1997
Efficacy and kinetics of bone marrow processing and enrichment of haematopoietic progenitor cells (HPC) by a large-volume apheresis procedureU Cassens, P Ostkamp-Ostermann, H Garritsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 1999
Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapyM Mohr, E Hilgenfeld, T Fietz, et al.
Transplantation Proceedings|November 15, 2002
Mycophenolate mofetil for the prophylaxis of acute graft-versus-host disease in stem cell transplant recipientsM G Kiehl, K Schäfer-Eckart, M Kröger, et al.
Thrombosis and Haemostasis|January 1, 1994
Factor VII-deficient substrate plasmas depleted of protein C raise the sensitivity of the factor VII bio-assay to activated factor VII: an international studyG J Miller, Y Stirling, M P Esnouf, et al.
Bone Marrow Transplantation|February 5, 2013
CD34(+) lineage specific donor cell chimerism for the diagnosis and treatment of impending relapse of AML or myelodysplastic syndrome after allo-SCTF Rosenow, A Berkemeier, U Krug, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2001
Simultaneous immunomagnetic CD34+ cell selection and B-cell depletion in peripheral blood progenitor cell samples of patients suffering from B-cell non-Hodgkin's lymphomaM Mohr, F Dalmis, E Hilgenfeld, et al.
Leukemia|July 3, 2002
Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemiaT Padró, R Bieker, S Ruiz, et al.
Blood|November 23, 2000
Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathwaysM Mizuki, R Fenski, H Halfter, et al.
Leukemia|April 2, 2011
Allogeneic stem cell transplant to eliminate germline mutations in the gene for CCAAT-enhancer-binding protein α from hematopoietic cells in a family with AMLM Stelljes, A Corbacioglu, R F Schlenk, et al.
Annals of Hematology|March 4, 2003
Reduced non-relapse mortality after reduced intensity conditioning in advanced chronic lymphocytic leukemiaJ Schetelig, C Thiede, M Bornhäuser, et al.
Pageof 9